Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
      • Top Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • Dermatology
  • Dermatology News
  • Optimizing...

Optimizing Periprocedural Success 1.0 in Dermo-Cosmetology: Non-Energy Based Interventions- Dr Sugandhan Selvendran

Written By : Dr. Sugandhan Selvendran Published On 2026-07-29T11:07:23+05:30  |  Updated On 29 July 2026 4:25 PM IST
Optimizing Periprocedural Success 1.0 in Dermo-Cosmetology: Non-Energy Based Interventions- Dr Sugandhan Selvendran
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Non-energy-based aesthetic procedures, comprising botulinum toxin injections, hyaluronic acid fillers, chemical peels, microneedling, and microdermabrasion, have emerged as cornerstone minimally invasive interventions in contemporary dermo-cosmetology. [1]These modalities currently command approximately 38.6% of India's aesthetic interventions’ market, yet clinical literature addressing periprocedural optimization for these procedures remains sparse. [2] Informed by the PRO-SUMMIT scientific meeting 2026, Bengaluru, this article provides evidence-based periprocedural protocols for optimizing outcomes with non-energy-based aesthetic interventions. [3]

Non-Energy-Based Aesthetic Procedures: Disrupting Skin Barrier & Need for Periprocedural Care

Chemical peels, microneedling, and microdermabrasion universally disrupt the skin barrier through controlled injury mechanisms, triggering transient trans-epidermal water loss (TEWL) and an inflammatory cascade. Critically, disruption severity, not procedure type, determines peri-procedural care intensity required. While most adverse effects are transient, significant complications include post-inflammatory hyperpigmentation, melasma exacerbation, microbial infection, and scarring, with substantially amplified risk in skin of color and acne-prone patients. Strategic periprocedural intervention combining pre-procedure photoprotection with anti-inflammatory and barrier-repair agents effectively mitigates these complications.[4]

Why Does Indian Skin Carry a Higher Periprocedural Risk?

Indian skin (predominantly Fitzpatrick IV–VI) presents unique procedural challenges with elevated risk of post-inflammatory hyperpigmentation (PIH), increased complications, and heightened sensitivity to resurfacing procedures. Recent evidence highlights that increased melanocyte activity and higher melanin production place this population at risk for PIH, hypopigmentation, and scarring. PIH typically presents 3–6 weeks post-procedure, requiring early intervention.[5] A strong inflammation–pigmentation link is established in this population. Additionally, significant psychosocial impact also necessitates customized protocols with rigorous pre- and post-procedure barrier care to mitigate periprocedural risks, improve outcomes, and patient satisfaction in Indian aesthetic practice.

Peri-Procedural Use pH 5.5-based Formulations in Dermo-Cosmetic Procedures: Potential Role

The pH-balanced formulations are essential for restoring the skin barrier–microbiome–acid mantle axis disrupted by aesthetic procedures. An acidic pH (~5.5) is fundamental to barrier integrity and microbiome homeostasis. Integrated pH-balanced (~5.5) skincare, combining gentle cleansers, moisturizers, and protective agents, across all procedural modalities- microneedling, energy-based devices, chemical peels, and microdermabrasion, minimizes post-procedural dysbiosis and erythema. Structured, phase-wise pH-balanced approaches support faster recovery, reduced adverse effects, and superior aesthetic outcomes. This approach is particularly critical in Indian skin to mitigate inflammation and PIH risk.

Barrier Conscious Framework for Non-Energy Based Interventions:

A structured three-phase pH (~5.5) protocol, tailored to skin type and procedural disruption severity, optimizes outcomes across non-energy aesthetic interventions and may be considered.

● Pre-Procedure Phase (2–4 weeks prior): Consider to initiate barrier-supportive care with a pH (~5.5) cleanser, probiotic serum (Lactococcus Ferment Lysate with triple hyaluronic acid and glycerin), and antioxidant protection cream (CoQ10 with botanical lipid matrix) to build baseline barrier resilience and reduce baseline irritation.

● Immediate Post-Procedure (Days 0–7): Apply seal-and-shield formulations; include triple hyaluronic acid for dry skin or hyaluronic acid gel for oily skin, combined with broad-spectrum SPF 50+ (tinted preferred) to minimize trans-epidermal water loss, attenuate inflammation, and provide photoprotection critical in skin of color.

● Maintenance Phase (Day 7+): Transition to barrier regeneration supportive regimen with Lactococcus Ferment Lysate and L-Fucose cream for collagen remodeling, supported by CoQ10 eye formulation when periorbital repair or rejuvenation procedures are involved.

It is prudent to align peri-procedural care intensity to the level of disruption, ensuring efficient, complication-free recovery.


Figure: Suggested Periprocedural Skincare Framework for Non-Energy-Based Interventions

Expert Panel & Consensus Recommendations

A 2026 published expert panel recommendation also strongly supported this clinical approach. An international panel of dermatologists and plastic surgeons suggested comprehensive periprocedural regimens emphasizing gentle cleansers, moisturizers, antioxidants, and broad-spectrum SPF 50+ sunscreen to reduce inflammation and PIH risk across all non-energy procedures. [6] Additionally, the Consensus Guide for Injectable and Nonenergy Cosmetic Procedures recommended establishing barrier-supportive routines 2–4 weeks pre-procedurally and using calming antioxidants, and depigmentation agents post-procedurally, particularly for Fitzpatrick IV–VI skin types.[7]

Key Takeaway

✔ Non-energy procedures disrupt the skin barrier, triggering TEWL and an inflammatory cascade; disruption severity determines peri-procedural care intensity required.

✔ Indian skin, typically Fitzpatrick IV–VI, presents elevated PIH risk, presenting 3–6 weeks post-procedure, necessitating early intervention and customized barrier-protective protocols.

✔ Experts recommend comprehensive periprocedural regimens with gentle cleansers, moisturizers, antioxidants, and SPF 50+ to reduce inflammation and PIH risk.

✔ Incorporating pH (~5.5) formulations supports restoring barrier integrity and microbiome homeostasis, minimizing dysbiosis, erythema, and adverse effects post-procedurally.

✔ A structured 3-phase pH (~5.5) protocol combining barrier-supportive ingredients, including Lactococcus Ferment Lysate, triple hyaluronic acid, CoQ10, L-Fucose, individualized to skin type and disruption severity, may help optimize outcomes, improve patient satisfaction, and ensure complication-free recovery.

Abbreviations: CoQ10, coenzyme Q10; HA, hyaluronic acid; PIH, post-inflammatory hyperpigmentation; SPF, sun protection factor; TEWL, transepidermal water loss.

References:
  • 1.Khan M, Singh R, Chaudhary A. 2025 India's medical aesthetic devices market: prospects and opportunities. Asian And Pacific Economic Review.208-218
  • 2.Mordor Intelligence. (2026-2031) India Aesthetic Devices Market Size & Share Analysis - Growth Trends and Forecast
  • 3.Dr BS Chandrashekhar 2026 PROSUMMIT
  • 4.Bjerring, P., Draelos, Z. D., Fabi, S. G., Goodman, G. J., Hau, K. C., Haus, A., Heydenrych, I., Kim, J., Lin, L. C., Sayed, K., Sundaram, H., Tsubouchi, R., Wu, Y., Brieva, P., Choudhary, H., & Xiang, L. F. (2026). International Expert Consensus on Integrated Skincare Active Ingredients for Pretreatment and Posttreatment Use With Medical Aesthetic Procedures to Enhance Skin Benefits.Journal of cosmetic dermatology,25
  • 5.Lee, S. S., Burgener, M. M., Sayyed, A. A., Catterall, L., Koljonen, J. L., Ruffolo, A., Cash, C. G., Lacerna Kimbrell, M., & Sommer, N. Z. (2026). Noninvasive Cosmetic Treatments for Fitzpatrick IV-VI: A Narrative Review of Safety and Efficacy Guidelines. Plastic and reconstructive surgery.Global open,14
  • 6.Nikolis, A., Nestor, M. S., Czuwara, J., Depfenhart, M., Fluhr, J. W., Addor, F. A. S. A., Piotrowski, K., Zielinski, Y., Lachmann, N., Prygova, I., Berlin, I., & Pellacani, G. (2026). Concomitant Use of Dermo-Cosmetic Skin Care in Aesthetic Procedures: Systematic Review with Expert Panel Recommendations.Clinical, cosmetic and investigational dermatology
  • 7.McDonald, C., Yip, L., Sullivan, J., Liu, W., Lin, F., & Goodman, G. (2025). A Guide to Periprocedural Skin Care Regimen for Injectable and Nonenergy Cosmetic Procedures Based on a Consensus of 6 Aesthetic Practitioners.Aesthetic surgery journal.
Dr Sugandhan Selvendranperiprocedural successdermatologydermo-cosmetologynon-energy based interventionsmicrodermabrasionPost inflammatory hyperpigmentation
Dr. Sugandhan Selvendran
Dr. Sugandhan Selvendran

    Dr. Sugandhan Selvendran is a senior dermatologist with over 20 years of experience in clinical dermatology, dermo-cosmetology, and hair restoration. He is the Head of Dermatology at MIOT International Hospitals and Medical Director of Dermalaya Skin & Hair Clinic, Chennai, with extensive academic contributions through publications, textbook chapters, and national faculty engagements.

    Print Article
    Show Full Article
    Next Story

    Editorial

    Oral Elagolix Achieves Greater Endometrioma Size Reduction and a Three-Fold Higher Conception Rate Compared to Leuprolide Depot: Indian Study

    Oral Elagolix Achieves Greater Endometrioma Size Reduction and a Three-Fold Higher Conception Rate...

    Dapagliflozin in IgA Nephropathy-associated CKD: What is the Evidence?

    Dapagliflozin in IgA Nephropathy-associated CKD: What is the Evidence?

    Loneliness in Healthy Aging - A Perspective

    Loneliness in Healthy Aging - A Perspective

    Is Heart Rate the Missing Target in Hypertension Management?

    Is Heart Rate the Missing Target in Hypertension Management?

    Telmisartan & Metoprolol in Hypertension & CV Care Continuum: 5 Key Points on Indias Most Widely Utilized ARB & Beta Blocker

    Telmisartan & Metoprolol in Hypertension & CV Care Continuum: 5 Key Points on India's Most Widely...

    View All

    Journal Club Today

    New Review Links Blueberry and Grape Polyphenols to Improved Vascular Function

    New Review Links Blueberry and Grape Polyphenols to Improved Vascular Function

    View All

    Health News Today

    Health Bulletin 29/July/2026

    Health Bulletin 29/July/2026

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok